Plasma phospholipid fatty acid composition in ischemic stroke: Importance of docosahexaenoic acid in the risk for intracranial atherosclerotic stenosis

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 418-424

  Kim, Yong Jae ^a   Kim, Oh Yoen ^b   Cho, Yoonsu ^c   Chung, Ji Hyung ^d   Jung, Young Sang ^e   Hwang, Geum Sook ^e   Shin, Min Jeong ^c  

^a Ewha Womans University   (South Korea)

^b Dong A University   (South Korea)

^c Korea University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Docosahexaenoic acid; Fatty acid; Intracranial atherosclerotic stenosis; Ischemic stroke

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTRACRANIAL ATHEROSCLEROTIC STENOSIS; KOREA; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CONSTRICTION, PATHOLOGIC; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHOSPHOLIPIDS; PRINCIPAL COMPONENT ANALYSIS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84869507004     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.007     Document Type: Article

References (46)

1. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease affects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58:2047-2067.
2. Tsuda K., Tsuda S., Minatogawa Y., Iwahashi H., Kido R., Masuyama Y. Decreased membrane fluidity of erythrocytes and cultured vascular smooth muscle cells in spontaneously hypertensive rats: an electron spin resonance study. Clin Sci (Lond) 1988, 75:477-480.
3. Singer P., Wirth M., Gerike U., Godicke W., Moritz V. Age dependent alterations of linolenic, arachidonic and eicosapentaenoic acids in renal and medulla of spontaneously hypertensive rats. Prostaglandins 1984, 27:375-390.
4. Larssona S.C., Virtamo J., Wolk A. Dietary fats and dietary cholesterol and risk of stroke in women. Atherosclerosis 2012, 221:282-286.
5. Montonen J., Järvinen R., Reunanen A., Knekt P. Fish consumption and the incidence of cerebrovascular disease. Br J Nutr 2009, 102:750-756.
6. He K., Song Y., Daviglus M.L., et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004, 35:1538-1542.
7. Hooper L., Thompson R.L., Harrison R.A., et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004, CD003177.
8. Tanaka K., Ishikawa Y., Yokoyama M., et al. Reduction in the recurrence of stroke by eicosa pentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 2008, 39:2052-2058.
9. Park S., Park S., Yi H., et al. Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 2009, 29:825-830.
10. Iso H., Sato S., Umemura U., et al. Linolenic acid, other fatty acids, and the risk of stroke. Stroke 2002, 33:2086-2093.
11. Tilvis R.S., Erkinjuntti T., Sulkava R., Farkkila M., Miettinen T.A. Serum lipids and fatty acids in ischemic strokes. Am Heart J 1987, 113:615-619.
12. Leung S.Y., Ng T.H., Yuen S.T., Lauder I.J., Ho F.C. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993, 24:779-786.
13. Gorelick P.B., Wong K.S., Bae H.J., Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008, 39:2396-2399.
14. Kasner S.E., Chimowitz M.I., Lynn M.J., Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006, 113:555-563.
15. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
16. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986, 27:114-120.
17. Lemaitre R.N., King I.B., Mozaffarian D., et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults. Circulation 2006, 114:209-215.
18. Do H.J., Chung H.K., Moon J., Shin M.J. Relationship between the estimates of desaturase activities and cardiometabolic phenotypes in Koreans. J Clin Biochem Nutr 2011, 49:135-141.
19. Iacono J.M., Puska P., Dougherty R.M., et al. Effects of dietary fat on blood pressure in a rural Finish population. Am J Clin Nutr 1983, 38:860-869.
20. Keys A., Parlin R.W. Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr 1966, 19:175-181.
21. Salomma V., Ahola I., Tumileho J., et al. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 1990, 39:1285-1291.
22. Renald S. Linolenic acid, platelet aggregation and myocardial infarction. Atherosclerosis 1990, 80:255-256.
23. Stark A.H., Crawford M.A., Reifen R. Update on alpha-linolenic acid. Nutr Rev 2008, 66:326-332.
24. Campos H., Baylin A., Willett W.C. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008, 118:339-345.
25. Nguemeni C., Delplanque B., Rovere C., et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 2010, 61:226-233.
26. Terano T., Hirai A., Hamazaki T., et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983, 46:321-331.
27. Bruckner G., Webb P., Greenwell L., Chow C., Richardson D. Fish oil increases peripheral capillary blood cell velocity in humans. Atherosclerosis 1987, 66:237-245.
28. Soyama Y., Miura K., Morikawa Y., et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the OYABE study. Stroke 2003, 34:863-868.
29. Lindenstrom E., Boysen G., Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. BMJ 1994, 309:11-15.
30. Tanne D., Yaari S., Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality: a 21-year follow-up of 8586 men from the Israeli ischemic heart disease study. Stroke 1997, 28:83-87.
31. Sacco R.L., Benson R.T., Kargman D.E., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA 2001, 285:2729-2735.
32. Bowman T.S., Sesso H.D., Ma J., et al. Cholesterol and the risk of ischemic stroke. Stroke 2003, 34:2930-2934.
33. Sanossina N., Saver J.L., Navad M., Ovbiagele B. High-density lipoprotein cholesterol: an emerging target for stroke treatment. Stroke 2007, 38:1104-1109.
34. Brewer H.B. Increasing HDL cholesterol levels. N Engl J Med 2004, 350:1491-1494.
35. Berliner J.A., Watson A.D. A role for oxidized phospholipids in atherosclerosis. N Engl J Med 2005, 353:9-11.
36. Navab M., Hama S.Y., Hough G.P., Subbanagounder G., Reddy S.T., Fogelman A.M. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 2001, 42:1308-1317.
37. Paterno R.R.A., Postiglione A., Hubsch A., Andresen I., Lang M.G. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004, 17:204-211.
38. Paterno R., Ruocco A., Cicale M., et al. Acute neuroprotective effect of high-density lipoprotein in experimental models of cerebral stroke (ABS). Stroke 2006, 37:729.
39. Laye S. Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot Essent Fatty Acids 2010, 82:295-303.
40. Orr S.K., Bazinet R.P. The emerging role of docosahexaenoic acid in neuroinflammation. Curr Opin Investig Drugs 2008, 9:735-743.
41. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: a positive modulator of akt signaling in neuronal survival. Proc Natl Acad Sci U S A 2005, 102:10858-10863.
42. Lalancette-Hèbert M., Julien C., Cordeau P., et al. Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage. Stroke 2011, 42:2903-2909.
43. Mulè G., Cusimano P., Cerasola G. The metabolic syndrome-arterial stiffness relationship in patients with ischaemic stroke: role of inflammation. Eur J Neurol 2008, 15:759-761.
44. Eslick G.D., Howe P.R., Smith C., Priest R., Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol 2009, 136:4-16.
45. Knapp H.R. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997, 65:1687S-1698S.
46. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.